论文部分内容阅读
目的观察应用新活素治疗老年人急性心力衰竭的临床疗效及不良反应。方法 86例老年急性心力衰竭患者随机分为对照组、治疗组,对照组给予常规抗急性心力衰竭治疗,治疗组在对照组治疗的基础上,再给予新活素治疗。观察两组患者的临床疗效及不良反应。结果治疗组老年急性心力衰竭患者在改善临床症状、降低血浆脑钠肽水平、提高左室射血分数方面治疗有效率明显优于对照组(P<0.05)。结论在老年急性心力衰竭患者治疗中应用新活素对改善患者症状、提高左室射血分数、降低血浆脑钠肽水平有一定的临床价值,且在老年患者中应用新活素安全可靠,值得在临床应用中进一步推广。
Objective To observe the clinical efficacy and adverse reactions of the application of neomycin in the treatment of elderly patients with acute heart failure. Methods Totally 86 elderly patients with acute heart failure were randomly divided into control group, treatment group and control group. The treatment group was given routine anti-acute heart failure treatment. The treatment group was treated with new survivin on the basis of the control group. The clinical efficacy and adverse reactions of the two groups were observed. Results The treatment group of elderly patients with acute heart failure in improving clinical symptoms, reduce plasma levels of brain natriuretic peptide, improve left ventricular ejection fraction treatment efficiency was significantly better than the control group (P <0.05). Conclusion The application of SVS in the treatment of elderly patients with acute heart failure has some clinical value in improving symptoms, increasing left ventricular ejection fraction, and lowering plasma BNP level. It is safe and reliable to use neomycin in elderly patients. In clinical application to further promote.